Literature DB >> 1936235

Spherocytosis and pulmonary hypertension coincidental occurrence or causal relationship?

D Verresen1, W De Backer, J Van Meerbeeck, I Neetens, E Van Marck, P Vermeire.   

Abstract

A report is given on a 59 yr old man with hereditary spherocytosis and progressive shortness of breath on exertion, due to severe pulmonary hypertension and cor pulmonale. An open lung biopsy was performed in order to exclude all known aetiologies of secondary pulmonary hypertension. Pathological examination revealed in situ thrombosis and asymmetric fibromuscular hyperplasia of small- and medium-sized pulmonary arteries. Both primary pulmonary hypertension and hereditary spherocytosis have a low incidence in the general population and their simultaneous occurrence has not been reported previously; the possibility that this was due to a causal relationship and not to coincidence cannot be ruled out, in view of some similarities with pulmonary hypertension complicating sickle cell anaemia.

Entities:  

Mesh:

Year:  1991        PMID: 1936235

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

2.  Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.

Authors:  Vikki G Nolan; Adeboye Adewoye; Clinton Baldwin; Ling Wang; Qianli Ma; Diego F Wyszynski; John J Farrell; Paola Sebastiani; Lindsay A Farrer; Martin H Steinberg
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

3.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

4.  Pseudohyperkalaemia associated with hereditary spherocytosis.

Authors:  O M Jolobe
Journal:  Postgrad Med J       Date:  1995-03       Impact factor: 2.401

5.  High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension.

Authors:  Nambirajan Sundaram; Anitaben Tailor; Laurel Mendelsohn; Janaka Wansapura; Xunde Wang; Tomoyasu Higashimoto; Michael W Pauciulo; William Gottliebson; Vijay K Kalra; William C Nichols; Gregory J Kato; Punam Malik
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

6.  Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.

Authors:  Roberto F Machado; A Kyle Mack; Sabrina Martyr; Christopher Barnett; Peter Macarthur; Vandana Sachdev; Inez Ernst; Lori A Hunter; Wynona A Coles; James P Nichols; Gregory J Kato; Mark T Gladwin
Journal:  Br J Haematol       Date:  2006-12-08       Impact factor: 6.998

7.  Pulmonary hypertension in well-transfused thalassemia major patients.

Authors:  Antonella Meloni; Jon Detterich; Alessia Pepe; Paul Harmatz; Tom D Coates; John C Wood
Journal:  Blood Cells Mol Dis       Date:  2014-11-24       Impact factor: 3.039

8.  Splenic infarction in a patient hereditary spherocytosis, protein C deficiency and acute infectious mononucleosis.

Authors:  Christian Breuer; Gisela Janssen; Hans-Jürgen Laws; Jörg Schaper; Ertan Mayatepek; Horst Schroten; Tobias Tenenbaum
Journal:  Eur J Pediatr       Date:  2008-07-05       Impact factor: 3.183

9.  Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?

Authors:  Sergey I Zharikov; Erik R Swenson; Miguel Lanaspa; Edward R Block; Jawaharlal M Patel; Richard J Johnson
Journal:  Med Hypotheses       Date:  2010-01-12       Impact factor: 1.538

10.  Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria.

Authors:  Zakari Y Aliyu; Victor Gordeuk; Vandana Sachdev; Aliyu Babadoko; Aisha I Mamman; Peter Akpanpe; Ester Attah; Yusuf Suleiman; Nurudeen Aliyu; Jamilu Yusuf; Laurel Mendelsohn; Gregory J Kato; Mark T Gladwin
Journal:  Am J Hematol       Date:  2008-06       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.